Analysis of the outcomes for selecting dexamethasone or methylprednisolone in treating PSM and SIPTW COVID-19 patients (N = 784) | ||||||
| PSM patients | SIPTW patients | ||||
Outcomes1 | Dexa N (%) | Methyl N (%) | 95% C.I | p2 | OR | P |
Recovered | 146 (37.2) | 143 (36.6) | −6.4, 7.6 | 0.93 | 1.04 | 0.8 |
Residual symptoms3 | 13 (3.3) | 12 (3.0) | −2.4, 2.9 | 1.0 | 1.62 | 0.3 |
Needs home O2 | 193 (49.1) | 174 (44.5) | −2.6, 11.8 | 0.22 | 0.75 | 0.055 |
Death | 41 (10.4) | 62 (15.8) | −10.4, 0.45 | 0.03 | 1.70 | 0.017 |